People who take the weight-loss medication Acomplia may boost their risk for severe depression and anxiety, Danish researchers report. Patients in a recent study were given either Acomplia or a placebo. Though patients given Acomplia did lose weight, they were also 2.5 times more likely to stop taking the med because of depression and three times more likely to stop the drug because of anxiety than those taking the placebo.
Read moreAbout a year ago, I wrote a two part blog regarding whether or not there was a "magic pill" for people who suffer from obesity. I went down... Read more »
On December 22, the FDA announced that they were alerting consumers not to purchase or consume more than 25 different products marketed for... Read more »
The U.S. Food and Drug Administration (FDA) has delayed the decision on whether to approve the weight-loss drug Acomplia. Drugmaker Sanofi-Aventis... Read more »
An advisory committee to the U.S. Food and Drug Administration (FDA) has recommended rejecting the obesity medication Acomplia. The med--called... Read more »
A new study suggests that the medication Acomplia may prevent and treat fatty liver disease. The study, led by the drug company that makes Acomplia,... Read more »
What do the European weight-loss drug Acomplia and marijuana have in common? They each affect the same part of the brain, says Dr. Mitchell Hecht.... Read more »
Police raids conducted in late April in five European countries dismantled a network of illegal Acomplia manufacturers. Investgators say the... Read more »